212 related articles for article (PubMed ID: 30685358)
1. Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers.
Peña-Bautista C; Baquero M; Vento M; Cháfer-Pericás C
Clin Chim Acta; 2019 Apr; 491():85-90. PubMed ID: 30685358
[TBL] [Abstract][Full Text] [Related]
2. A new model for the pathophysiology of Alzheimer's disease. Aluminium toxicity is exacerbated by hydrogen peroxide and attenuated by an amyloid protein fragment and melatonin.
van Rensburg SJ; Daniels WM; Potocnik FC; van Zyl JM; Taljaard JJ; Emsley RA
S Afr Med J; 1997 Sep; 87(9):1111-5. PubMed ID: 9358827
[TBL] [Abstract][Full Text] [Related]
3. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.
Butterfield DA; Lauderback CM
Free Radic Biol Med; 2002 Jun; 32(11):1050-60. PubMed ID: 12031889
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update.
Bradley-Whitman MA; Lovell MA
Arch Toxicol; 2015 Jul; 89(7):1035-44. PubMed ID: 25895140
[TBL] [Abstract][Full Text] [Related]
5. The role of free radicals in canine counterpart of senile dementia of the Alzheimer type.
Skoumalova A; Rofina J; Schwippelova Z; Gruys E; Wilhelm J
Exp Gerontol; 2003 Jun; 38(6):711-9. PubMed ID: 12814808
[TBL] [Abstract][Full Text] [Related]
6. F2-isoprostanes in Alzheimer and other neurodegenerative diseases.
Montine TJ; Montine KS; McMahan W; Markesbery WR; Quinn JF; Morrow JD
Antioxid Redox Signal; 2005; 7(1-2):269-75. PubMed ID: 15650414
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease.
Williams TI; Lynn BC; Markesbery WR; Lovell MA
Neurobiol Aging; 2006 Aug; 27(8):1094-9. PubMed ID: 15993986
[TBL] [Abstract][Full Text] [Related]
8. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.
Bassett CN; Neely MD; Sidell KR; Markesbery WR; Swift LL; Montine TJ
Lipids; 1999 Dec; 34(12):1273-80. PubMed ID: 10652986
[TBL] [Abstract][Full Text] [Related]
10. Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes.
McIntosh LJ; Trush MA; Troncoso JC
Free Radic Biol Med; 1997; 23(2):183-90. PubMed ID: 9199880
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
[TBL] [Abstract][Full Text] [Related]
12. Oxidative alterations in Alzheimer's disease.
Markesbery WR; Carney JM
Brain Pathol; 1999 Jan; 9(1):133-46. PubMed ID: 9989456
[TBL] [Abstract][Full Text] [Related]
13. End products of lipid peroxidation in erythrocyte membranes in Alzheimer's disease.
Skoumalová A; Mádlová P; Topinková E
Cell Biochem Funct; 2012 Apr; 30(3):205-10. PubMed ID: 22161584
[TBL] [Abstract][Full Text] [Related]
14. Lipid peroxidation in aging brain and Alzheimer's disease.
Montine TJ; Neely MD; Quinn JF; Beal MF; Markesbery WR; Roberts LJ; Morrow JD
Free Radic Biol Med; 2002 Sep; 33(5):620-6. PubMed ID: 12208348
[TBL] [Abstract][Full Text] [Related]
15. The lipid peroxidation products as possible markers of Alzheimer's disease in blood.
Skoumalová A; Ivica J; Santorová P; Topinková E; Wilhelm J
Exp Gerontol; 2011 Jan; 46(1):38-42. PubMed ID: 20920571
[TBL] [Abstract][Full Text] [Related]
16. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
[TBL] [Abstract][Full Text] [Related]
17. Lipoproteins and lipid peroxidation in Alzheimer's disease.
Bassett CN; Montine TJ
J Nutr Health Aging; 2003; 7(1):24-9. PubMed ID: 12679837
[TBL] [Abstract][Full Text] [Related]
18. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
Reed TT; Pierce WM; Markesbery WR; Butterfield DA
Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
[TBL] [Abstract][Full Text] [Related]
19. F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease.
Montine TJ; Quinn J; Kaye J; Morrow JD
J Mol Neurosci; 2007 Sep; 33(1):114-9. PubMed ID: 17901555
[TBL] [Abstract][Full Text] [Related]
20. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics.
Sultana R; Perluigi M; Butterfield DA
Antioxid Redox Signal; 2006; 8(11-12):2021-37. PubMed ID: 17034347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
